0001231919-25-000318.txt : 20251015 0001231919-25-000318.hdr.sgml : 20251015 20251015142037 ACCESSION NUMBER: 0001231919-25-000318 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251015 DATE AS OF CHANGE: 20251015 EFFECTIVENESS DATE: 20251015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Belhaven Biopharma Inc. CENTRAL INDEX KEY: 0001873965 ORGANIZATION NAME: EIN: 851622238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560900 FILM NUMBER: 251394423 BUSINESS ADDRESS: STREET 1: 150 FAYETTEVILLE STREET STREET 2: SUITE 2300 CITY: RALEIGH STATE: NC ZIP: 27601 BUSINESS PHONE: 919-541-9366 MAIL ADDRESS: STREET 1: 150 FAYETTEVILLE STREET STREET 2: SUITE 2300 CITY: RALEIGH STATE: NC ZIP: 27601 FORMER COMPANY: FORMER CONFORMED NAME: Belhaven BioPharma Inc. DATE OF NAME CHANGE: 20210720 D 1 primary_doc.xml X0708 D LIVE 0001873965 Belhaven Biopharma Inc. 84406 Winslow Chapel Hill NC NORTH CAROLINA 27517 919-656-8658 DELAWARE Belhaven BioPharma Inc. Corporation true 2020 Scott David Lyman 84406 Winslow Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director President and Chief Executive Officer David Algon Neal 84406 Winslow Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director Chief Financial Officer and Secretary Wes Wheeler 84406 Winslow Chapel Hill NC NORTH CAROLINA 27517 Director Derek Winstanly 84406 Winslow Chapel Hill NC NORTH CAROLINA 27517 Director Pharmaceuticals Decline to Disclose 06b false 2025-08-04 false true true false 0 32289627 32289627 0 false 222 0 0 0 false Belhaven Biopharma Inc. /s/ Scott David Lyman Scott David Lyman President and Chief Executive Officer 2025-10-15